rs10821163 PHF2 PTSD risk and expression changes

Key takeaways

  • PTSD risk linked to the variant
  • Reduced expression in brain cerebellum and thyroid tissue
  • Increased expression in colon transverse, esophagus mucosa, visceral omentum, skeletal muscle
  • Reduced expression in skin sun exposed lower leg

Key takeaways

  • PTSD risk linked to the variant
  • Reduced expression in brain cerebellum and thyroid tissue
  • Increased expression in colon transverse, esophagus mucosa, visceral omentum, skeletal muscle
  • Reduced expression in skin sun exposed lower leg

What the research says The GWAS Catalog shows rs10821163 is associated with PTSD risk, with a reported effect size of 7.25 and p=4e-13 in about 1.3 million individuals [PMID 38637617]. GTEx expression data indicate reduced expression in brain cerebellum and thyroid tissue GTEx Portal.

Reported associations

  • PTSD: the variant is associated with higher risk, effect size 7.25 p=4e-13 [PMID 38637617].

Evidence quality The evidence is based on a single GWAS Catalog association in about 1.3 million individuals with effect size 7.25 and p=4e-13 [PMID 38637617]. No replication data are provided, so the finding remains preliminary.

Tissue-specific expression effects

  • PHF2: reduced expression in brain cerebellum and thyroid tissue GTEx Portal
  • FAM120AOS: increased expression in colon transverse, esophagus mucosa, visceral omentum, and skeletal muscle GTEx Portal
  • WNK2: reduced expression in skin sun exposed lower leg GTEx Portal

Lifestyle considerations No lifestyle considerations on file for this variant.

Frequently asked questions

What does rs10821163 mean?

rs10821163 is a genetic variant in the PHF2 gene that has been linked to higher risk of post-traumatic stress disorder and shows reduced expression in brain cerebellum and thyroid tissue.

Is this variant associated with any other conditions?

The GWAS Catalog reports only an association with PTSD; no other conditions are reported for rs10821163.